Drug intelligence / Profile preview

diatrizoate meglumine

Development stage
Approved
Lead developer
Bracco Diagnostics
Modality
Small Molecules
Administration
Intravenous, Intra-arterial, Oral, Rectal, Intravesical, Intraurethral
01

Overview

Diatrizoate meglumine is an iodinated, water-soluble radiopaque contrast agent used primarily to enhance imaging in diagnostic procedures such as retrograde cystourethrography, gastrointestinal studies, angiography, and urography. It works by increasing the contrast of internal body structures on radiographic images due to its high iodine content, which absorbs X-rays. This agent is administered intravenously or via other routes depending on the procedure and is indicated for use under medical supervision[1][2][3][5]. Its primary mechanism of action is physical—providing radiopacity rather than acting through a biochemical target.

Brand names
CystografinCystografin-DiluteHypaque-CystoHypaque MeglumineReno-30Reno30Reno 30Reno-60Reno60Reno 60Reno-DipGastrografinRenocal 76Renocal76Renocal-76RenografinMD-Gastroview
Other names
diatrizoate meglumine

Beyond the preview

Go deeper on diatrizoate meglumine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diatrizoate meglumine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call